Global Needle-free Drug Delivery Devices Market

Needle-free Drug Delivery Devices Market Size, Share, Growth Analysis, By Technology(Jet injectors, Transdermal patches, and Inhalation-based systems), By End-user(Hospitals and Clinics to Home Healthcare Settings), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2250 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 61 | Figures: 74

Needle-free Drug Delivery Devices Market News

  • PharmaJet is a leading biotech company in needle-free injection technology. The leading jet injector provider was bought by Penjet Corporation in February 2023. Penjet Corporation is a private company specializing in proprietary drug delivery systems and a manufacturer of needle-free injectors. This purchase will make Penjet a key player in the needle-free drug delivery market. They can achieve this by broadening their product range.
  • Antares Pharma is a specialized pharma product development company that focuses on self-injection, pharmaceutical products and technologies. This company bought Apostrophe in January 2023. Apostrophe is a development company that focuses on the design and development of microneedle-based drug delivery patches. This purchase will grant Antares Pharma access to the microneedle-based drug delivery market. They can do so by widening the range of their product offerings.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Needle-free Drug Delivery Devices Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The needle-free drug delivery devices market is defined by its competitive environment. This landscape includes all market players striving to gain the largest market share. This intense competition has driven the market’s growth. Some industry leaders include 3M, Pfizer, Johnson & Johnson, and Medtronic. These companies dominate the market. They have achieved this by using their best advantages. They include tremendous R&D efforts and a wide range of products. 'Becton, Dickinson and Company (BD) (USA)', 'Zogenix (USA)', 'Pfizer Inc. (USA)', 'Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)', 'Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)', 'PharmaJet (USA)', '3M (USA)', 'National Medical Products Inc. (NMP Pharma) (USA)', 'Antares Pharma (USA)', 'Crossject (France)', 'Novartis AG (Switzerland)', 'Bioject Medical Technologies Inc. (USA)', 'Pharmajet (USA)', 'Astrazeneca (UK)', 'Eli Lilly and Company (USA)', 'MedImmune (USA, a subsidiary of AstraZeneca)', 'Genentech (USA, a subsidiary of Roche)', 'Inovio Pharmaceuticals (USA)', 'Valeritas (USA)'

Advancements in Technology: The market has seen the entry of new devices which are more precisely efficient. This is because of the continuous improvements in needle-free drug delivery technology. The introduction of advanced devices like transdermal patches, along with micro-needles and jet injectors, has been made possible with this development. These new technologies can be applied to many cases. These tools are only becoming more precise and are suited to varying applications as technology keeps developing.

Expanding Applications in Healthcare: The market was witnessing a notable trend. Drug delivery devices that didn’t use needles could be applied elsewhere apart from traditional insulin and vaccines delivery. The market also served specialized therapeutics and biologic in addition to its previous purposes. Technological advancements can be credited for the use of these devices in additional applications. As the requirement for controlled and accurate drug administration persists, the market can expect further innovations and uses.

The market’s dominant region is North America. Its increased usage of innovative technologies in the field of medicine and a well-established healthcare infrastructure has steeled its top market position. Other factors that contribute to North America’s supremacy are its supportive regulatory framework and continuous R&D efforts.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Connected Drug Delivery Devices Market
Buy Now GET FREE SAMPLE
Drug Delivery Market
Buy Now GET FREE SAMPLE
Microneedle Drug Delivery Systems Market
Buy Now GET FREE SAMPLE
Controlled Release Drug Delivery Market
Buy Now GET FREE SAMPLE
Vaccine Delivery Devices Market
Buy Now GET FREE SAMPLE
Pen Needles Market
Buy Now GET FREE SAMPLE
Needles Market
Buy Now GET FREE SAMPLE
Pharmaceutical Processing and Packaging Equipment Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Needle-free Drug Delivery Devices Market

Report ID: SQMIG35I2250

$5,300
BUY NOW GET FREE SAMPLE